Meditera Tibbi Malzeme Sanayi ve Ticaret AS Total Assets

Latest as of March 2026: TL3.82 Billion TRY ≈ $85.56 Million USD

Meditera Tibbi Malzeme Sanayi ve Ticaret AS total assets. Based on the latest financial reports, Meditera Tibbi Malzeme Sanayi ve Ticaret AS (MEDTR) holds total assets worth TL3.82 Billion TRY (≈ $85.56 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see MEDTR company net worth for the company's overall valuation and market capitalisation.

Total Assets of Meditera Tibbi Malzeme Sanayi ve Ticaret AS (2018–2025)

Total assets of Meditera Tibbi Malzeme Sanayi ve Ticaret AS from 2018 to 2025. This chart illustrates how Meditera Tibbi Malzeme Sanayi ve Ticaret AS's total assets have evolved over time, based on quarterly financial data. See Meditera Tibbi Malzeme Sanayi ve Ticaret share price for real-time trading data and today's change.

Meditera Tibbi Malzeme Sanayi ve Ticaret AS - Asset Composition Analysis

Meditera Tibbi Malzeme Sanayi ve Ticaret AS Total Assets Breakdown (December 2025)

Meditera Tibbi Malzeme Sanayi ve Ticaret AS total assets breakdown as of December 2025. Meditera Tibbi Malzeme Sanayi ve Ticaret AS's total assets of TL3.82 Billion consist of 50.7% current assets and 49.3% non-current assets.

Asset Category	Amount (TRY)	% of Total Assets
Cash & Equivalents	TL0.00	8.8%
Accounts Receivable	TL760.92 Million	21.2%
Inventory	TL550.44 Million	15.3%
Property, Plant & Equipment	TL0.00	0.0%
Intangible Assets	TL14.39 Million	0.4%
Goodwill	TL64.54 Million	1.8%

Asset Composition Trend (2018–2025)

This chart illustrates how Meditera Tibbi Malzeme Sanayi ve Ticaret AS's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Meditera Tibbi Malzeme Sanayi ve Ticaret current assets vs equity to assess how much short-term liquidity the company maintains relative to its equity base.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Meditera Tibbi Malzeme Sanayi ve Ticaret AS's current assets represent 50.7% of total assets in 2025, a decrease from 75.3% in 2018.
Cash Position: Cash and equivalents constituted 8.8% of total assets in 2025, up from 6.9% in 2018.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, an increase from 0.0% in 2018.
Asset Diversification: The largest asset category is accounts receivable at 21.2% of total assets.

Meditera Tibbi Malzeme Sanayi ve Ticaret AS Competitors by Total Assets

Key competitors of Meditera Tibbi Malzeme Sanayi ve Ticaret AS based on total assets are shown below.

Company	Country	Total Assets
Cochlear Ltd AU:COH	Australia	AU$2.83 Billion
Vitrolife AB ST:VITR	Sweden	Skr11.30 Billion
Sinocare Inc SHE:300298	China	CN¥6.25 Billion
Shanghai Sanyou Medical Co Ltd SHG:688085	China	CN¥2.34 Billion
Zhejiang Orient Gene Biotech Co Ltd SHG:688298	China	CN¥7.51 Billion
Nanjing Vishee Medical Technology Co Ltd SHG:688580	China	CN¥1.79 Billion
TAIDOC TECHNOLOGY CORP TW:4736	Taiwan	NT$13.07 Billion
SS Innovations International Inc. Common Stock NASDAQ:SSII	USA	$96.98 Million

Meditera Tibbi Malzeme Sanayi ve Ticaret AS - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	3.58	3.65	5.31
Quick Ratio	2.49	2.39	4.48
Cash Ratio	0.00	0.00	0.00
Working Capital	TL1.37 Billion	TL1.20 Billion	TL370.69 Million

Meditera Tibbi Malzeme Sanayi ve Ticaret AS - Advanced Valuation Insights

This section examines the relationship between Meditera Tibbi Malzeme Sanayi ve Ticaret AS's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	0.87
Latest Market Cap to Assets Ratio	0.01
Asset Growth Rate (YoY)	-2.4%
Total Assets	TL3.59 Billion
Market Capitalization	$38.78 Million USD

Valuation Analysis

Below Book Valuation: The market values Meditera Tibbi Malzeme Sanayi ve Ticaret AS's assets below their book value (0.01x), which may indicate investor concerns about asset quality or future growth.

Slight Asset Contraction: Meditera Tibbi Malzeme Sanayi ve Ticaret AS's assets decreased by 2.4% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for Meditera Tibbi Malzeme Sanayi ve Ticaret AS (2018–2025)

The table below shows the annual total assets of Meditera Tibbi Malzeme Sanayi ve Ticaret AS from 2018 to 2025.

Year	Total Assets	Change
2025-12-31	TL3.59 Billion ≈ $80.42 Million	-2.38%
2024-12-31	TL3.68 Billion ≈ $82.38 Million	+34.59%
2023-12-31	TL2.73 Billion ≈ $61.21 Million	+148.57%
2022-12-31	TL1.10 Billion ≈ $24.63 Million	+52.87%
2021-12-31	TL719.21 Million ≈ $16.11 Million	+110.49%
2020-12-31	TL341.69 Million ≈ $7.65 Million	+55.16%
2019-12-31	TL220.21 Million ≈ $4.93 Million	+8.23%
2018-12-31	TL203.47 Million ≈ $4.56 Million	--

About Meditera Tibbi Malzeme Sanayi ve Ticaret AS

IS:MEDTR Turkey Medical Devices

Market Cap

$38.78 Million

TL1.73 Billion TRY

Market Cap Rank

#22582 Global

#322 in Turkey

Share Price

TL18.25

Change (1 day)

+1.39%

52-Week Range

TL16.96 - TL32.70

All Time High

TL52.90